# Endo Daily Vs Intermittent Vit D Over 50

> Recommends daily, lower-dose vitamin D instead of nondaily, higher-dose vitamin D for adults aged 50 years and older who have an indication for vitamin D supplementation. Trigger phrases include 'vitamin D dosing strategy for patients over 50', 'daily versus intermittent vitamin D in older adults', and 'vitamin D supplementation plan for adults 50+ requiring treatment'.

- Skill: `dromlakhani/endo-daily-vs-intermittent-vit-d-over-50` (Agent Skill)
- Install (CLI): `npx skillmds@latest add dromlakhani/endo-daily-vs-intermittent-vit-d-over-50`
- Raw SKILL.md: https://api.skillmd.com/api/skills/dromlakhani/endo-daily-vs-intermittent-vit-d-over-50/raw
- Safety review: pending (external: skill-scanner PASS, skillspector PASS)
- Works with: Claude Code, Claude.ai, OpenAI Codex
- Category: Coding & Dev Tools
- Author: dromlakhani (https://skillmd.com/u/dromlakhani)
- Updated: 2026-09-08
- Page: https://skillmd.com/skills/dromlakhani/endo-daily-vs-intermittent-vit-d-over-50

---


# Daily vs intermittent vitamin D dosing in adults over 50

## STEP 1 — Gather Information
Collect patient age, confirmation of an indication for vitamin D supplementation (e.g., osteoporosis, known deficiency, malabsorption, chronic kidney disease, etc.), and verify the patient is not pregnant (if applicable). Record these data.

## STEP 2 — Rule In / Rule Out
If the patient is aged 50 years or older AND has an indication for vitamin D supplementation, proceed to Step 3; otherwise, do not apply this recommendation and consider age‑specific dosing per other guidelines.

## STEP 3 — Classify or Stratify
Assess for risk factors that increase adverse event potential with intermittent high‑dose vitamin D (history of hypercalcemia, nephrolithiasis, renal impairment, or medications that accelerate vitamin D catabolism). If any risk factor is present, classify as high risk; otherwise, classify as standard risk.

## STEP 4 — Decide
Recommend daily lower‑dose vitamin D (e.g., 600–800 IU per day from fortified foods, supplements, or a combination) and counsel against intermittent high‑dose regimens (e.g., 50 000 IU weekly or monthly). In patients classified as high risk, emphasize avoidance of intermittent dosing due to increased safety concerns.

## Clinical Guardrails / Mimics / Pitfalls
Do not use intermittent high‑dose vitamin D (e.g., 50 000 IU weekly or monthly) in adults ≥50 y with an indication for vitamin D; do not rely on routine 25(OH)D testing to guide dosing in this population; do not exceed the tolerable upper intake level (4000 IU/day) without monitoring for hypercalcemia; do not apply this recommendation to pregnant individuals without obstetric guidance.

## Concrete Clinical Example
A 62‑year‑old postmenopausal woman with osteoporosis initiates vitamin D supplementation. She is >50 y, has an indication (osteoporosis), and has no history of kidney stones or hypercalcemia. Prescribe vitamin D 800 IU daily and advise against monthly 50 000 IU doses.

**Source:** Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2024, DOI: 10.1210/clinem/dgae290